Clinical Trial Update: Aripiprazole Treatment of the Prodrome [NA]

View source ↗

Summary

The clinical trial evaluating aripiprazole for prodromal schizophrenia/psychosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Northwell Health | Conditions: Prodromal Schizophrenia, Prodromal Psychosis | NA | Status: TERMINATED